2024
Eyebrow and Eyelash Loss in Patients With Cancer.
Rose L, Khuhro A, Minta A, Novice M, Novice T, Lustberg M, Ruddy K, Rake E, Loprinzi C, Dulmage B. Eyebrow and Eyelash Loss in Patients With Cancer. Journal Of Drugs In Dermatology 2024, 23: 327-331. PMID: 38709698, DOI: 10.36849/jdd.8003.Peer-Reviewed Original ResearchConceptsPrevention optionsRadiation therapyTopical vasoconstrictorEndocrine therapyEyelash lossTreatment optionsPrescription medicationsCancer treatmentPatientsScalp coolingHair lossRobust researchMadarosisPermanent tattoosTherapyCancerTreatmentEyebrowsEyelash hairScalpOptionsChemotherapyCryotherapyVasoconstrictorDermatologistsFeasibility and metabolic outcomes of a well-formulated ketogenic diet as an adjuvant therapeutic intervention for women with stage IV metastatic breast cancer: The Keto-CARE trial
Buga A, Harper D, Sapper T, Hyde P, Fell B, Dickerson R, Stoner J, Kackley M, Crabtree C, Decker D, Robinson B, Krystal G, Binzel K, Lustberg M, Volek J. Feasibility and metabolic outcomes of a well-formulated ketogenic diet as an adjuvant therapeutic intervention for women with stage IV metastatic breast cancer: The Keto-CARE trial. PLOS ONE 2024, 19: e0296523. PMID: 38166036, PMCID: PMC10760925, DOI: 10.1371/journal.pone.0296523.Peer-Reviewed Original ResearchConceptsMetastatic breast cancerStage IV metastatic breast cancerKetogenic dietInsulin resistanceNutritional ketosisPlasma insulinBreast cancerBody compositionAdjuvant therapeutic interventionsMetabolic outcomesCancer patientsPlasma glucoseMetabolic effectsBody fatShort-term studiesBody weightPleiotropic mechanismsTherapeutic interventionsConsistent bloodPhase IMonthsWomenCancerAd libitumChemotherapy
2023
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Bhatia S, Pappo A, Acquazzino M, Allen-Rhoades W, Barnett M, Borinstein S, Casey R, Choo S, Chugh R, Dinner S, Ermoian R, Fair D, Federman N, Folbrecht J, Gandhi S, Germann J, Goldsby R, Hayashi R, Huang A, Huang M, Jacobs L, Lee-Miller C, Link M, Livingston J, Lustberg M, Malogolowkin M, Oeffinger K, Pratilas C, Reed D, Skiles J, von Mehren M, Yeager N, Montgomery S, Hang L. Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network 2023, 21: 851-880. PMID: 37549914, DOI: 10.6004/jnccn.2023.0040.Peer-Reviewed Original ResearchConceptsYoung Adult OncologyAYA patientsAdult oncologyNCCN guidelinesNCCN Clinical Practice GuidelinesClinical practice guidelinesSupportive care servicesFertility counselingRisk factorsComprehensive carePractice guidelinesCare servicesPatientsOlder adultsOncologyCancerUnique needsGuidelinesAdolescentsBehavioral issuesDiagnosisCareP13-029-23 Cross-Sectional Associations of Serum Fatty Acids and Self-Reported Cognitive Outcomes in Women With Breast Cancer Undergoing Chemotherapy
Melink Z, Schnell P, Ormiston K, Weinhold K, Kopec R, Lustberg M, Orchard T. P13-029-23 Cross-Sectional Associations of Serum Fatty Acids and Self-Reported Cognitive Outcomes in Women With Breast Cancer Undergoing Chemotherapy. Current Developments In Nutrition 2023, 7: 100485. DOI: 10.1016/j.cdnut.2023.100485.Peer-Reviewed Original ResearchA review of the impact of energy balance on triple-negative breast cancer
Akingbesote N, Owusu D, Liu R, Cartmel B, Ferrucci L, Zupa M, Lustberg M, Sanft T, Blenman K, Irwin M, Perry R. A review of the impact of energy balance on triple-negative breast cancer. JNCI Monographs 2023, 2023: 104-124. PMID: 37139977, DOI: 10.1093/jncimonographs/lgad011.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsTriple-negative breast cancerInterventional studyBreast cancerCancer treatmentClinical interventional studyClinical observationalImmune activationCancer outcomesCancer careClinical studiesOverall healthEnergy intakeNarrative reviewCancer cellsEnergy expenditureCancerTreatmentEnergy balanceOutcomesExerciseReviewDetrimental effectsImmunotherapyStudyIntakeOnline description of services provided in adult survivorship programs across U.S. accredited cancer centers
Anampa-Guzmán A, Contreras-Chavez P, Lustberg M, Nekhlyudov L. Online description of services provided in adult survivorship programs across U.S. accredited cancer centers. Journal Of Cancer Survivorship 2023, 18: 79-83. PMID: 36933086, DOI: 10.1007/s11764-023-01361-w.Peer-Reviewed Original ResearchCancer CenterSurvivorship programsAdult survivorsCancer survivorship servicesCancer SurvivorsOur studyChildhood-onset cancersCancer survivorship programNew cancer casesSpecific cancer typesSurvivorship servicesMetastatic diseaseSmoking cessationPurposeThe American CollegeCancer casesAmerican CollegeCare plansCancer typesProgram websitesGenetic counselingPatientsCancerSurvivorsAdultsPsychology servicesLimited descriptionCase Study in Chemotherapy-Induced Neuropathy: Tango Dance Improved Over-Ground Local Gait Stability
Glover N, WIlder J, Patrick S, Hackney M, Lustberg M, Worthen-Chaudhari L. Case Study in Chemotherapy-Induced Neuropathy: Tango Dance Improved Over-Ground Local Gait Stability. Archives Of Physical Medicine And Rehabilitation 2023, 104: e16. DOI: 10.1016/j.apmr.2022.12.044.Peer-Reviewed Original ResearchChemotherapy-induced neuropathyGait stability indexBreast cancerGait stabilityTango danceDynamic gait stabilityOncology outpatientsBC survivorsSteady-state gaitGait assessmentClinical utilityNeuromechanical functionNeuropathyBalance deficitsInterventionFurther studiesHuman applicationSurvivorsMovement variabilityWeeksTest assessmentAssessmentOutpatientsCancerPerson's resistanceHair loss during and after breast cancer therapy
Rose L, Lustberg M, Ruddy K, Cathcart-Rake E, Loprinzi C, Dulmage B. Hair loss during and after breast cancer therapy. Supportive Care In Cancer 2023, 31: 186. PMID: 36826602, DOI: 10.1007/s00520-023-07634-5.Peer-Reviewed Original ResearchConceptsTreatment optionsHair lossDistressing side effectsChemotherapy-induced alopeciaCancer therapyBreast cancer therapyEndocrine therapyMajor surgeryPatient counselingTelogen effluviumBreast cancerBreast oncologistsSide effectsPrevention strategiesAlopeciaTherapyChemotherapyPatientsSurgeryOncologistsOptionsEtiologyCancer
2022
Right Sizing Systemic Therapy for Patients with Breast Cancer. Where are we Today?
Williams N, Grimm M, Gast K, Lustberg M. Right Sizing Systemic Therapy for Patients with Breast Cancer. Where are we Today? Current Breast Cancer Reports 2022, 14: 142-152. DOI: 10.1007/s12609-022-00463-1.Peer-Reviewed Original ResearchEarly-stage breast cancerBreast cancerSystemic therapyClinical outcomesER-positive breast cancerTriple-negative breast cancerBreast cancer supportRobust clinical outcomesOptimized clinical outcomesQuality of lifePersonalized medicine approachNeoadjuvant regimensAdditional therapyEndocrine therapySelect patientsClinical trialsBest therapyPrognostic biomarkerPatientsCancer supportTherapyMedicine approachCancerRoutine useGenomic testingLevering internet-based discussion data from gynecological cancer survivors to inform survivorship care: A mixed methods thematic analysis approach.
Adams E, Tallman D, Haynam M, Nekhlyudov L, Lustberg M. Levering internet-based discussion data from gynecological cancer survivors to inform survivorship care: A mixed methods thematic analysis approach. Journal Of Clinical Oncology 2022, 40: e24143-e24143. DOI: 10.1200/jco.2022.40.16_suppl.e24143.Peer-Reviewed Original ResearchGynecological cancer survivorsCancer survivorsSurvivorship careGynecologic cancer survivorsEffects of cancerExperience of survivorshipSurvivorship InitiativeSurvivorship practicesSurvivorship settingsUterine cancerOvarian cancerPatient experienceHealth insurance issuesThematic analysisPsychosocial aspectsFinancial toxicitySurvivorsCare frameworkThematic analysis approachCancerCaregiver relationshipCareInsurance issuesPsychosocial themesCLO22-079: A Phase II Open-Label Study of Subcutaneous CpG ODN (PF03512676) in Combination With Trastuzumab in Patients With Metastatic Breast Cancer
Quiroga D, Pinette A, Benner B, Schwarz E, Wesolowski R, Stiff A, Zelinskas S, Macrae E, Lustberg M, Mrozek E, Ramaswamy B, Carson W. CLO22-079: A Phase II Open-Label Study of Subcutaneous CpG ODN (PF03512676) in Combination With Trastuzumab in Patients With Metastatic Breast Cancer. Journal Of The National Comprehensive Cancer Network 2022, 20: clo22-079. DOI: 10.6004/jnccn.2021.7196.Peer-Reviewed Original Research
2021
Changes in Inflammatory Markers and Correlations with Serum Polyunsaturated Fatty Acids In Postmenopausal Women With Breast Cancer Undergoing Chemotherapy
Zhang Z, Ormiston K, Weinhold K, Schnell P, Kopec R, Lustberg M, Orchard T. Changes in Inflammatory Markers and Correlations with Serum Polyunsaturated Fatty Acids In Postmenopausal Women With Breast Cancer Undergoing Chemotherapy. Journal Of The Academy Of Nutrition And Dietetics 2021, 121: a18. DOI: 10.1016/j.jand.2021.06.034.Peer-Reviewed Original Research316P Attitudes towards the use of stereotactic body radiation therapy in oligometastatic breast cancer: Results of an OncoAlert survey
Vukovic P, Meattini I, Lambertini M, de Azambuja E, Prat A, Aftimos P, Lustberg M, Kruljac I, Morgan G. 316P Attitudes towards the use of stereotactic body radiation therapy in oligometastatic breast cancer: Results of an OncoAlert survey. Annals Of Oncology 2021, 32: s502-s503. DOI: 10.1016/j.annonc.2021.08.599.Peer-Reviewed Original ResearchReal-world data on usage of scalp cooling for chemotherapy associated alopecia in the United States.
Williams N, Paxman R, Thornhill E, Kassem M, Grimm M, Dulmage B, Cathcart-Rake E, Ruddy K, Pariser A, Gatti-Mays M, Cherian M, VanDeusen J, Stover D, Sardesai S, Wesolowski R, Ramaswamy B, Loprinzi C, Lustberg M. Real-world data on usage of scalp cooling for chemotherapy associated alopecia in the United States. Journal Of Clinical Oncology 2021, 39: e18739-e18739. DOI: 10.1200/jco.2021.39.15_suppl.e18739.Peer-Reviewed Original ResearchScalp coolingNational Comprehensive Cancer NetworkMedical Oncology guidelinesComprehensive Cancer NetworkMajority of patientsOncology guidelinesCategory 2ABreast cancerHair lossCancer NetworkSide effectsChemotherapyLargest reportPatientsReal-world useOlder adultsScalpEuropean SocietyFurther studiesAlopeciaCancerDescriptive statisticsGenitourinaryLungGynecologyBPI21-008: Patient Preferences and Treatment Adherence to Adjuvant Ovarian Suppression Among Premenopausal Women With Hormone Receptor Positive Breast Cancer
Sukumar J, Quiroga D, Kassem M, Grimm M, Shinde N, Appiah L, Palettas M, Stephens J, Cherian M, Stover D, Williams N, Van Deusen J, Wesolowski R, Lustberg M, Ramaswamy B, Sardesai S. BPI21-008: Patient Preferences and Treatment Adherence to Adjuvant Ovarian Suppression Among Premenopausal Women With Hormone Receptor Positive Breast Cancer. Journal Of The National Comprehensive Cancer Network 2021, 19: bpi21-008. DOI: 10.6004/jnccn.2020.7759.Peer-Reviewed Original Research
2020
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
Mayo SJ, Lustberg M, M. Dhillon H, Nakamura ZM, Allen DH, Von Ah D, C. Janelsins M, Chan A, Olson K, Tan CJ, Toh YL, Oh J, Grech L, Cheung YT, Subbiah IM, Petranovic D, D’Olimpio J, Gobbo M, Koeppen S, Loprinzi CL, Pang L, Shinde S, Ntukidem O, Peters KB. Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group. Supportive Care In Cancer 2020, 29: 2821-2840. PMID: 33231809, DOI: 10.1007/s00520-020-05860-9.Peer-Reviewed Original ResearchConceptsCancer-related cognitive impairmentNon-central nervous system cancersNervous system cancersOncology providersSystem cancersNon-central nervous system malignanciesCognitive impairmentNervous system malignanciesQuality of lifeOncology cliniciansStudy groupFunctional abilityPatientsCancerImpairmentContext of adultProvidersMalignancyCliniciansDiseaseCaregiversAssociation of pre-existing mental illness with all-cause and cancer-specific mortality among Medicare beneficiaries with pancreatic cancer
Paredes AZ, Hyer JM, Tsilimigras DI, Palmer E, Lustberg MB, Dillhoff ME, Cloyd JM, Tsung A, Ejaz A, Wells-Di Gregorio S, Pawlik TM. Association of pre-existing mental illness with all-cause and cancer-specific mortality among Medicare beneficiaries with pancreatic cancer. Hepato Pancreato Biliary 2020, 23: 451-458. PMID: 32843275, DOI: 10.1016/j.hpb.2020.08.002.Peer-Reviewed Original ResearchConceptsCancer-specific mortalityLong-term outcomesPancreatic cancerMental illnessPre-existing mental illnessSchizophrenic disordersHigh riskMedicare beneficiariesCancer-directed surgerySEER-Medicare databasePre-existing historyAnxiety/depressionEarly-stage cancerCause mortalityMultivariable analysisPancreatic adenocarcinomaStage cancerPsychotic disordersPatientsBipolar disorderIllnessCancerMortalityDisordersDepressionNeuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice
Huang KM, Leblanc AF, Uddin ME, Kim JY, Chen M, Eisenmann ED, Gibson A, Li Y, Hong KW, DiGiacomo D, Xia S, Alberti P, Chiorazzi A, Housley SN, Cope TC, Sprowl JA, Wang J, Loprinzi CL, Noonan A, Lustberg M, Cavaletti G, Pabla N, Hu S, Sparreboom A. Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice. Journal Of Clinical Investigation 2020, 130: 4601-4606. PMID: 32484793, PMCID: PMC7456253, DOI: 10.1172/jci136796.Peer-Reviewed Original ResearchConceptsOrganic cation transporter 2Peripheral neurotoxicityColorectal cancerOxaliplatin-induced peripheral neurotoxicityOxaliplatin-containing therapyOxaliplatin-induced neurotoxicitySatellite glial cellsOxaliplatin neurotoxicityChronic formCancer patientsGlial cellsPreclinical modelsPreventive strategiesMouse modelPharmacological approachesPharmacological targetingTranslational significanceNeurotoxicityTransporter 2PatientsUptake transportersCancerAnticancer drugsCandidate transportersSolute carriersPalliative Care Referral Patterns for Adolescent and Young Adult Patients at a Comprehensive Cancer Center
Lockwood BJ, Ntukidem OL, Ehrman SE, Schnell PM, Klemanski DL, Bhatnagar B, Lustberg M. Palliative Care Referral Patterns for Adolescent and Young Adult Patients at a Comprehensive Cancer Center. Journal Of Adolescent And Young Adult Oncology 2020, 10: 109-114. PMID: 32706607, DOI: 10.1089/jayao.2020.0081.Peer-Reviewed Original ResearchConceptsPalliative careReferral patternsHigh symptom burdenRetrospective chart reviewYoung adult patientsComprehensive cancer centerEligible patientsSpecific cancer typesAdult patientsChart reviewSymptom burdenOncologic treatmentCancer CenterLung cancerInpatient settingPoor survivalCancer typesPatientsYoung adultsCancerGreater penetranceSmall percentageAdolescentsValuable rolePC accessRacial/Ethnic Disparities in Hospice Utilization Among Medicare Beneficiaries Dying from Pancreatic Cancer
Paredes AZ, Hyer JM, Palmer E, Lustberg MB, Pawlik TM. Racial/Ethnic Disparities in Hospice Utilization Among Medicare Beneficiaries Dying from Pancreatic Cancer. Journal Of Gastrointestinal Surgery 2020, 25: 155-161. PMID: 32193849, DOI: 10.1007/s11605-020-04568-9.Peer-Reviewed Original ResearchConceptsEthnic minority patientsPancreatic cancerHospice utilizationMinority patientsHospice servicesWhite patientsMedicare Standard Analytic FilesRacial/Ethnic DisparitiesStandard Analytic FilesDeceased individualsTime of deathOverall low useClinical factorsMost patientsMultivariable analysisAnalytic FilesMedicare beneficiariesPancreatectomyPatientsComparable oddsEthnic disparitiesCancerLogistic regressionLow useDeath